Experts urge stronger industry‑academia ties to boost India’s biopharma status
Published · Updated
AI-generated summary of the coverage listed below: A group of experts has called for deeper collaboration between Indian industry and academia to position the country as a global biopharmaceutical hub. They argue that stronger partnerships would accelerate research, development, and commercialization of drugs, helping India compete with established biopharma centers worldwide. The initiative aims to enhance innovation, attract investment, and improve access to advanced therapies for the Indian population.
Covered by 5 outlets across the spectrum: 20% left, 60% center, 20% right.
Who is covering this story
- Left-leaning (1): The Hindu
- Center (3): Indian Express, Deccan Herald, Free Press Journal
- Right-leaning (1): Sunday Guardian
Sources
- Members call for constructive engagement for pathogen access, benefit sharing — Indian Express (center)
- Directing India’s R&D rupee from research to results — Sunday Guardian (right-leaning)
- India should aim to become global leader in lab-grown diamonds, jewellery sector: Amit Shah — Deccan Herald (center)
- US, India Join Forces To Strengthen Global Undersea Cable Security, Boost India’s Emergence As A Major Digital Connectivity Hub — Free Press Journal (center)
- Experts call for stronger industry-academia partnerships to make India a global biopharma hub — The Hindu (left-leaning)